Menu
ÚHKT

Ing. David Kundrát

výzkumný a vývojový pracovník

Tel: +420 221 977 363
Email: David.Kundrat@uhkt.cz

Impaktované publikace

[1]

Szikszai, K.; Krejcik, Z.; Klema, J.; Loudova, N.; Hrustincova, A.; Belickova, M.; Hruba, M.; Vesela, J.; Stranecky, V.; Kundrat, D.; Pecherkova, P.; Cermak, J.; Jonasova, A.; Dostalova Merkerova, M.

LncRNA profiling reveals that the deregulation of H19, WT1-AS, TCL6, and LEF1-AS1 is associated with higher-risk myelodysplastic syndrome

[rok vydání 2020, impact factor 6.639 ]

[2]

Koralkova, P.; Belickova, M.; Kundrat, D.; Dostalova Merkerova, M.; Krejcik, Z.; Szikszai, K.; Kaisrlikova, M.; Vesela, J.; Vyhlidalova, P.; Stetka, J.; Hlavackova, A.; Suttnar, J.; Flodr, P.; Stritesky, J.; Jonasova, A.; Cermak, J.; Divoky, V.

Low plasma citrate levels and specific transcriptional signatures associated with quiescence of CD34+ progenitors predict Azacitidine therapy failure in MDS/AML patients

[rok vydání 2021, impact factor 6.639 ]

[3]

Hrustincova, A.; Krejcik, Z.; Kundrat, D.; Szikszai, K.; Belickova, M.; Pecherkova, P.; Klema, J.; Vesela, J.; Hruba, M.; Cermak, J.; Hrdinova, T.; Krijt, M.; Valka, J.; Jonasova, A.; Merkerova, M.D.

Circulating small noncoding RNAs have specific expression patterns in plasma and extracellular vesicles in myelodysplastic syndromes and are predictive of patient outcome

[rok vydání 2020, impact factor 6.600 ]

[4]

Šestáková, Š.; Cerovská, E.; Cyril Šálek, C.; Kundrát, D.; Ježíšková, I.; Folta, A.; Mayer, J.; Ráčil, Z.; Cetkovský, P.; Remešová, H.

A validation study of potential prognostic DNA methylation biomarkers in patients with acute myeloid leukemia using a custom DNA methylation sequencing panel

[rok vydání 2022, impact factor 6.551 ]

[5]

Curik, N.; Polivkova, V.; Burda, P.; Koblihova, J.; Laznicka, A.; Kalina, T.; Kanderova, V.; Brezinova, J.; Ransdorfova, S.; Karasova, D.; Rejlova, K.; Bakardjieva, M.; Kuzilkova, D.; Kundrat, D.; Linhartova, J.; Klamova, H.; Salek, C.; Klener, P.; Hrusak, O.; Machova Polakova, K.

Somatic mutations in oncogenes are in chronic myeloid leukemia acquired de novo via deregulated base-excision repair and alternative non-homologous end joining

[rok vydání 2021, impact factor 6.244 ]

[6]

Dostalova Merkerova, M.; Krejcik, Z.; Szikszai, K.; Kundrat, D.

Circular RNAs in hematopoiesis with a focus on acute myeloid leukemia and myelodysplastic syndrome

[rok vydání 2020, impact factor 5.923 ]

[7]

Votavova, H.; Urbanova, Z.; Kundrat, D.; Dostalova Merkerova, M.; Vostry, M.; Hruba, M.; Cermak, J.; Belickova, M.

Modulation of the immune response by deferasirox in myelodysplastic syndrome patients

[rok vydání 2021, impact factor 5.863 ]

[8]

Dostalova Merkerova, M.; Klema, J.; Kundrat, D.; Szikszai, K.; Krejcik, Z.; Hrustincova, A.; Trsova, I.; Le, A.V.; Cermak, J.; Jonasova, A.; Belickova, M.

Noncoding RNAs and their response predictive value in azacitidine-treated patients with myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia-related changes

[rok vydání 2022, impact factor 4.069 ]